Analystreport

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $24.00 price target on the stock.

Corbus Pharmaceuticals Holdings, Inc.  (CRBP) 
Last corbus pharmaceuticals holdings, inc. earnings: 3/12 07:05 am Check Earnings Report
US:NASDAQ Investor Relations: corbuspharma.com